Research-stage product concept

Connected support from signal to recovery.

EpiCircle brings the intended seizure-event workflow into one place: multimodal signal review, human confirmation, caregiver escalation, consent-based location, medication routines and recovery follow-up.

Simulated experience · Not a medical device · Does not diagnose epilepsy or replace emergency care.
CAREGIVER ALERTSara · awaiting receiptDemo only — no message sent
EpiCircle10:24
Normal patternMonitoring baseline
Heart rate74 bpm
Motion0.18 g
CONSENT-BASED LOCATIONToronto sample pointClearly labelled — not patient data
The problem

Families are asked to coordinate too much across disconnected tools.

During and after a seizure, timing, communication, medication information and recovery checks can sit in different places. EpiCircle is designed around the whole care pathway—not a single alert.

⌁

Fragmented signals

Wearables, observations and seizure diaries may not form one understandable event record.

♡

Uncertain response

Families need to know who was alerted, who acknowledged and when escalation remains unresolved.

✓

Incomplete follow-through

Medication routines, recovery checks and information for later clinical review are often separate.

The proposed system

A closed-loop pathway built around five connected jobs.

Each layer has a defined role. AI supports pattern recognition, while people remain responsible for confirmation, care and clinical decisions.

1SenseReview motion, autonomic signals and device quality together.
2ConfirmGive the user a visible chance to cancel or confirm concern.
3AlertEscalate through a care circle and show receipt status.
4SupportKeep timing, location and the clinician-approved plan together.
5LearnCreate a structured record for later review and model improvement.
Product capabilities

Designed for the event, the response and the days between events.

AI

Explainable event evidence

Shows which signal groups contributed to a suspected ongoing convulsive pattern and whether signal quality was sufficient.

00

Event timer and action plan

Makes duration visible and keeps the individualized, clinician-approved action plan within reach.

♡

Care Circle escalation

Supports up to four prioritized caregivers with acknowledgement and escalation status.

⌖

Consent-based location

Requests location only with explicit consent and distinguishes real GPS from presentation-only sample points.

Rx

Medication routine support

Lets the patient self-confirm a scheduled dose and record concerns without recommending dose changes.

✓

Recovery and reassurance

Keeps acknowledgement, breathing, responsiveness, injury and return-to-baseline checks visible until completed.

Important: medication changes remain a clinician decision. The product concept never tells a patient to increase, reduce or stop a prescribed dose.
Interactive product demo

Follow one fictional event from baseline to recovery.

Click each step or use the Next button. All names, signals, locations and acknowledgements are simulated.

EpiCircle guided walkthroughSIMULATED DATA · NO REAL ALERTS
STEP 1 OF 5

Baseline monitoring

The device first checks wear status and signal quality.

LIVE MONITOR · CONCEPT
✓
Normal patternNo alert prepared
Motion
18%
Autonomic
12%
Deviation
9%
EVENT TIMER00:00Not started
CAREGIVERNot alertedDemo contact: Sara
LOCATIONNot sharedConsent-controlled
Signal quality comes before event interpretation.
Who it is designed for

One shared picture, tailored to each participant.

●

People living with epilepsy

  • Clear event status and timer
  • Medication routine confirmation
  • Control over contacts and location consent
♡

Families and caregivers

  • Visible receipt and escalation status
  • Individual action-plan access
  • Structured post-event reassurance checks
+

Clinical and research partners

  • Reviewable event timelines
  • False-alert and outcome labels
  • A foundation for prospective validation
Safety, trust and boundaries

The interface should make uncertainty visible—not hide it.

Safety principles in the concept

✓Human confirmation before escalation whenever appropriate
✓Signal-quality and wear-status checks
✓Visible acknowledgement and unresolved-state tracking
✓Explicit consent before requesting location
✓Audit timestamps and false-alert feedback

What is not claimed

!It does not diagnose epilepsy.
!It does not predict all seizures or detect every seizure type.
!It does not replace emergency services or clinical judgment.
!It does not change medication doses.
!Current messaging, calling and AI detection remain simulated.
Development pathway

From an interactive MVP to a validated product.

This roadmap separates presentation-ready experience design from the evidence and infrastructure required for a real medical product.

PHASE 1 · NOWConcept and usability MVPTest workflows, language, accessibility and family needs with fictional data.
PHASE 2Data and algorithm studyDefine target event, collect consented multimodal data and establish annotation protocols.
PHASE 3Prospective validationEvaluate sensitivity, false alarms, subgroup performance and real-world usability.
PHASE 4Secure product and regulatory pathBuild integrations, privacy controls, quality systems and jurisdiction-specific regulatory evidence.
Project leadership

An interdisciplinary project built around patient and family needs.

NA
Niknaz AkbarpourFounder & Project Lead · Honours Psychology, Neuroscience & Behaviour (B.Sc.) · McMaster University
VS
Dr. Vahid Salehi FarClinical Advisor

Shares clinical perspective to help identify seizure-related signs that may be useful to track.

EB
Ehsan BolourianEngineering & Technical Advisor

Contributes early technical discussions, including possibilities for future AI development.

AN
Dr. Atieh NowrouziAI Advisor · Founder, TSV

Provides strategic guidance on AI development and the pathway from concept to a responsible product.

Frequently asked questions

Clear answers before the product is real-world ready.

No. The current experience is an interactive MVP using simulated sensor and event data. Real detection requires a defined device, consented datasets and prospective clinical validation.

No. It demonstrates the alert, escalation and acknowledgement workflow but does not send real messages, calls or emergency requests.

No. It may support adherence to a prescribed schedule and collect concerns, but dose changes must remain with the prescribing clinician.

A paediatric pathway would require separate co-design, guardian consent, age-appropriate usability work, safeguarding and clinical validation. The present MVP should not be presented as validated for children.

Time-synchronized wearable signals, device-quality metadata, video/clinical reference where ethically approved, precise event timing, expert labels, medication and contextual variables, plus non-seizure daily activity to measure false alarms.

Contact and collaboration

Help shape a responsible seizure-support product.

Research, clinical and technical conversations are welcome.

EpiCircle is seeking thoughtful feedback from people living with epilepsy, families, clinicians, researchers, engineers and potential community partners. Please do not send urgent or identifiable patient information by email.

Email the project lead

Explore the working MVP.

Test caregiver setup, event timing, sample location, medication confirmation and recovery follow-up.

Open research MVPReplay website demoResearch MVP · Simulated data · ChatGPT sign-in and approved access required